1887

Chapter 19 : Fungal-Bacterial Interactions

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Fungal-Bacterial Interactions, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap19-1.gif /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap19-2.gif

Abstract:

This chapter describes a number of in vitro systems that have been used to model different aspects of fungal biology in naturally occurring complex, host-associated communities. The authors have divided fungal-bacterial model systems into categories based on the in vivo community that they seek to model. First, fungal-bacterial interactions associated with opportunistic infections are addressed. Subsequently, models designed to elucidate interactions in the oral microflora, intestinal environment, and the female reproductive tract are discussed. The chapter talks about the challenges and potential benefits of translating what has been learned with in vitro model systems to the analyses of in vivo fungal-bacterial communities. In general, when and or are found together in the lungs of cystic fibrosis (CF) patients, the numbers of fungal cells remain relatively small until patients are treated with antibacterial compounds that attenuate the infection. The study of - interactions in an in vitro model system might provide tools to better understand how these mycobacteria cause disease in the human lungs and how mixed bacterial-fungal infections could negatively impact the patient. Antibiotic-based studies may also be useful for creating model systems for the in vivo analysis of fungal-bacterial interactions on skin or on the mucosal surfaces of the mouth or female reproductive tract. Ultimately, the authors not only aim at predicting how microbes interact with one another but also determining the part that the host plays in governing and responding to different microbial communities.

Citation: Hogan D, Kolter R. 2006. Fungal-Bacterial Interactions, p 261-269. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch19

Key Concept Ranking

Reverse Transcriptase PCR
0.44259456
Lactic Acid Bacteria
0.4046157
Opportunistic Fungal Infections
0.40166938
Candida albicans
0.40000004
0.44259456
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Interactions between and . (A) biofilm surrounding a filament after 24 h of coincubation in conditioned M63 medium (35). (B) survival in (●) cell-free culture supernatant and (■) in conditioned medium containing 10 cells/ml.

Citation: Hogan D, Kolter R. 2006. Fungal-Bacterial Interactions, p 261-269. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch19
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2.
Figure 2.

Complex interactions affecting host-associated microbial communities.

Citation: Hogan D, Kolter R. 2006. Fungal-Bacterial Interactions, p 261-269. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch19
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815776.ch19
1. Adam, B.,, G. S. Baillie, and, L. J. Douglas. 2002. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol. 51:344349.
2. Adlerberth, I.,, S. Ahrne,, M. L. Johansson,, G. Molin,, L. A. Hanson, and, A. E. Wold. 1996. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl. Environ. Microbiol. 62:22442251.
3. Aksoy, D. Y.,, A. Turker,, M. K. Altundag,, H. Abali,, M. Durusu,, M. Erman,, A. Uner,, A. A. Sungur,, S. Unal, and, O. Uzun. 2003. Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemia. Chemotherapy 49:264266.
4. Bagg, J., and, R. W. Silverwood. 1986. Coagglutination reactions between Candida albicans and oral bacteria. J. Med. Microbiol. 22:165169.
5. Baillie, G. S., and, L. J. Douglas. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:19001905.
6. Bakare, N.,, V. Rickerts,, J. Bargon, and, G. Just-Nubling. 2003. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 46:1923.
7. Barsby, T.,, M. T. Kelly, and, R. J. Andersen. 2002. Tupuseleiamides and basiliskamides, new acyldipeptides and antifungal polyketides produced in culture by a Bacillus laterosporus isolate obtained from a tropical marine habitat. J. Nat. Prod. 65:14471451.
8. Beninati, C.,, M. R. Oggioni,, M. Boccanera,, M. R. Spinosa,, T. Maggi,, S. Conti,, W. Magliani,, F. De Bernardis,, G. Teti,, A. Cassone,, G. Pozzi, and, L. Polonelli. 2000. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18:10601064.
9. Bernhardt, H.,, K. Zimmermann, and, M. Knoke. 1999. The continuous flow culture as an in vitro model in experimental mycology. Mycoses 42:2932.
10. Bhargava, V.,, J. F. Tomashefski, Jr.,, R. C. Stern, and, C. R. Abramowsky. 1989. The pathology of fungal infection and colonization in patients with cystic fibrosis. Hum. Pathol. 20:977986.
11. Bollert, F. G.,, P. J. Sime,, W. MacNee, and, G. K. Crompton. 1994. Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination? Thorax49:521522.
12. Boris, S., and, C. Barbés. 2000. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes. Infect. 2:543546.
13. Boris, S.,, J. Suárez,, F. Vázquez, and, C. Barbés. 1998. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 66:19851989.
14. Branting, C.,, M. L. Sund, and, L. E. Linder. 1989. The influence of Streptococcus mutans on adhesion of Candida albicans to acrylic surfaces in vitro. Arch. Oral Biol. 34:347353.
15. Braun, B. R., and, A. D. Johnson. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105109.
16. Braun, P. C.,, R. F. Hector,, M. E. Kamark,, J. T. Hart, and, R. L. Cihlar. 1987. Effect of cerulenin and sodium butyrate on chitin synthesis in Candida albicans. Can. J. Microbiol. 33:546550.
17. Burns, J.,, J. Van Dalfsen,, R. Shawar,, K. Otto,, R. Garber,, J. Quan,, A. Montgomery,, G. Albers,, B. Ramsey, and, A. Smith. 1999. Effect of intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J. Infect. Dis. 179:11901196.
18. Busscher, H. J.,, R. H. Free,, R. Van Weissenbruch,, F. W. Albers, and, H. C. Van Der Mei. 2000. Preliminary observations on influence of dairy products on biofilm removal from silicone rubber voice prostheses in vitro. J. Dairy Sci. 83:641647.
19. Cheng, S. H.,, R. J. Gregory,, J. Marshall,, S. Paul,, D. W. Souza,, G. A. White,, C. R. O’Riordan, and, A. E. Smith. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell63:827834.
20. Danna, P. L.,, C. Urban,, E. Bellin, and, J. J. Rahal. 1991. Role of Candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet 337:511514.
21. Darling, W. M. 1976. Co-cultivation of mycobacteria and fungus. Lancet ii:740.
22. Demirezen, S. 2002. The Lactobacilli-Candida relationship in cervico-vaginal smears. Cent. Eur. J. Public Health10:9799.
23. Domingue, P. A.,, K. Sadhu,, J. W. Costerton,, K. Bartlett, and, A. W. Chow. 1991. The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin. Med. 67:226231.
24. Donlan, R. M., and, J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167193.
25. Elmer, G. W.,, C. M. Surawicz, and, L. V. McFarland. 1996. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870876.
26. Fitzsimmons, N., and, D. R. Berry. 1994. Inhibition of Candida albicans by Lactobacillus acidophilus : evidence for the involvement of a peroxidase system. Microbios 80:125133.
27. Fonzi, W. A. 2002. Role of pH response in Candida albi-cans virulence. Mycoses 45 (Suppl. 1):1621.
28. Giuliano, M.,, M. Barza,, N. V. Jacobus, and, S. L. Gorbach. 1987. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob. Agents Chemother. 31:202206.
29. Grimaudo, N. J., and, W. E. Nesbitt. 1997. Coaggregation of Candida albicans with oral Fusobacterium species. Oral Microbiol. Immunol. 12:168173.
30. Grimaudo, N. J.,, W. E. Nesbitt, and, W. B. Clark. 1996. Coaggregation of Candida albicans with oral Actinomyces species. Oral Microbiol. Immunol. 11:5961.
31. Gupta, T. P., and, M. N. Ehrinpreis. 1990. Candida- associated diarrhea in hospitalized patients. Gastroenterology 98:780785.
32. Haase, G.,, H. Skopnik,, T. Groten,, G. Kusenbach, and, H. G. Posselt. 1991. Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 34:373376.
33. Hermann, C.,, J. Hermann,, U. Munzel, and, R. Ruchel. 1999. Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses 42:619627.
34. Hoberg, K. A.,, R. L. Cihlar, and, R. A. Calderone. 1983. Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans. Antimicrob. Agents Chemother. 24:401408.
35. Hogan, D. A., and, R. Kolter. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:22292232.
36. Hogan, D. A.,, A. Vik, and, R. Kolter. 2004. A Pseudomonas aeruginosa quorum sensing molecule inhibits Candida albi-cans filamentation. Mol. Microbiol. 54:1212.
37. Hogenauer, C.,, H. F. Hammer,, G. J. Krejs, and, E. C. Reisinger. 1998. Mechanisms and management of antibiotic-associated diarrhea. Clin. Infect. Dis. 27:702710.
38. Holmes, A. R.,, R. McNab, and, H. F. Jenkinson. 1996. Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions. Infect. Immun. 64:46804685.
39. Jeavons, H. S. 2003. Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus. J. Obstet. Gynecol. Neonatal Nurs. 32:287296.
40. Johnston, I. D. 1988. Mycobacterium xenopi infection and aspergilloma. Tubercle 69:139143.
41. Kennedy, M. J., and, P. A. Volz. 1983. Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice. Sabouraudia 21:2733.
42. Kennedy, M. J., and, P. A. Volz. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 23:265273.
43. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165:11681176.
44. Kerr, J. 1994. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J. Infect. 28:305310.
45. Kerr, J. R.,, G. W. Taylor,, A. Rutman,, N. Hoiby,, P. J. Cole, and, R. Wilson. 1999. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52:385387.
46. Kinder, S., and, S. Holt. 1994. Coaggregation between bacterial species. Methods Enzymol. 236:254269.
47. Kohno, S.,, T. Hatano,, H. Yamada,, S. Maesaki,, A. Yasuoka,, M. Kaku,, H. Koga, and, K. Hara. 1992. Superinfection of chronic necrotizing pulmonary aspergillosis by Mycobacterium tuberculosis. Intern. Med. 31:540543.
48. Kolenbrander, P. E.,, R. N. Andersen,, K. Kazmerzak,, R. Wu, and, R. J. Palmer, Jr. 1999. Spatial organization of oral bacteria in biofilms. Methods Enzymol. 310:322332.
49. Krasner, R. I.,, G. Young, and, P. L. Yudkofsky. 1956. Interactions of oral strains of Candida albicans and lacto-bacilli. J. Bacteriol. 72:525529.
50. Krause, R.,, E. Schwab,, D. Bachhiesl,, F. Daxbock,, C. Wenisch,, G. J. Krejs, and, E. C. Reisinger. 2001. Role of Candida in antibiotic-associated diarrhea. J. Infect. Dis. 184:10651069.
51. Kuhn, D. M., and, M. A. Ghannoum. 2004. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr. Opin. Investig. Drugs 5:186197.
52. Lavermicocca, P.,, F. Valerio,, A. Evidente,, S. Lazzaroni,, A. Corsetti, and, M. Gobbetti. 2000. Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl. Environ. Microbiol. 66:40844090.
53. Lavermicocca, P.,, F. Valerio, and, A. Visconti. 2003. Antifungal activity of phenyllactic acid against molds isolated from bakery products. Appl. Environ. Microbiol. 69:634640.
54. Maccato, M. L., and, R. H. Kaufman. 1991. Fungal vulvovaginitis. Curr. Opin. Obstet. Gynecol. 3:849852.
55. Marrie, T. J., and, J. W. Costerton. 1981. The ultrastructure of Candida albicans infections. Can. J. Microbiol. 27:11561164.
56. Mastella, G.,, M. Rainisio,, H. K. Harms,, M. E. Hodson,, C. Koch,, J. Navarro,, B. Strandvik, and, S. G. McKenzie. 2000. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur. Respir. J. 16:464471.
57. Millsap, K. W.,, R. Bos,, H. C. Van Der Mei, and, H. J. Busscher. 2000. Dot assay for determining adhesive interactions between yeasts and bacteria under controlled hydrodynamic conditions. J. Microbiol. Methods 40:225232.
58. Millsap, K. W.,, R. Bos,, H. C. van der Mei, and, H. J. Busscher. 1999. Influence of aeration of Candida albicans during culturing on their surface aggregation in the presence of adhering Streptococcus gordonii. FEMS Immunol. Med. Microbiol. 26:6974.
59. Moosa, M. Y.,, J. D. Sobel,, H. Elhalis,, W. Du, and, R. A. Akins. 2004. Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium. Antimicrob. Agents Chemother. 48:161167.
60. Navarro, J.,, M. Rainisio,, H. K. Harms,, M. E. Hodson,, C. Koch,, G. Mastella,, B. Strandvik, and, S. G. McKenzie. 2001. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur. Respir. J. 18:298305.
61. Noverr, M. C., and, G. B. Huffnagle. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 72:62066210.
62. Odds, F. C. 1988. Candida and Candidosis, 2nd ed. Baillière Tindall, London, United Kingdom.
63. Ponnuvel, K. M.,, R. Rajkumar,, T. Menon, and, V. S. Sankaranarayanan. 1996. Role of Candida in indirect pathogenesis of antibiotic associated diarrhea in infants. Mycopathologia 135:145147.
64. Rajan, S., and, L. Saiman. 2002. Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 17:4756.
65. Ramage, G.,, K. Vande Walle,, B. L. Wickes, and, J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:24752479.
66. Reed, B. D. 1992. Risk factors for Candida vulvovaginitis. Obstet. Gynecol. Surv. 47:551560.
67. Reid, G. 2001. Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 73:437S443S.
68. Rogers, T., and, E. Balish. 1976. Experimental Candida albicans infection in conventional mice and germfree rats. Infect. Immun. 14:3338.
69. Romano, J., and, R. Kolter. 2005 Pseudomonas-Saccharomyces interactions: influence of fungal metabolism on bacterial physiology and survival. J. Bacteriol. 187:940948.
70. Ruhnke, M. 2002. Skin and mucous membrane infections, p. 307326. In R. A. Calderone (ed.), Candida and Candidiasis. ASM Press, Washington, D.C.
71. Samonis, G.,, A. Gikas,, E. Anaissie,, G. Vrenzos,, S. Maraki,, Y. Tselentis, and, G. Bodey. 2003. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents Chemother. 37:5153.
72. Sanderson, P. J., and, S. S. Bukhari. 1991. Candida spp. and Clostridium difficile toxin-negative antibiotic-associated diarrhoea. J. Hosp. Infect. 19:142143.
73. Sandine, W. E. 1976. Roles of Lactobacillus in the intestinal tract. J. Food Prot. 42:259262.
74. Schinabeck, M. K.,, L. A. Long,, M. A. Hossain,, J. Chandra,, P. K. Mukherjee,, S. Mohamed, and, M. A. Ghannoum. 2004. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob. Agents Chemother. 48:17271732.
75. Sherertz, R. J.,, I. I. Raad,, A. Belani,, L. C. Koo,, K. H. Rand,, D. L. Pickett,, S. A. Straub, and, L. L. Fauerbach. 1990. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J. Clin. Microbiol. 28:7682.
76. Shin, E. S.,, S. C. Chung,, Y. K. Kim,, S. W. Lee, and, H. S. Kho. 2003. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96:4853.
77. Sjovall, J.,, B. Huitfeldt,, L. Magni, and, C. E. Nord. 1986. Effect of beta-lactam prodrugs on human intestinal microflora. Scand. J. Infect. Dis. Suppl. 49:7384.
78. Smith, M. G.,, S. G. Des Etages, and, M. Snyder. 2004. Microbial synergy via an ethanol-triggered pathway. Mol. Cell. Biol. 24:38743884.
79. Sobel, J. D., and, W. Chaim. 1996. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J. Clin. Microbiol. 34:24972499.
80. Suci, P. A., and, B. J. Tyler. 2003. A method for discrimination of subpopulations of Candida albicans biofilm cells that exhibit relative levels of phenotypic resistance to chlorhexidine. J. Microbiol. Methods 53:313325.
81. Thomas, J. G.,, G. Ramage, and, J. L. Lopez-Ribot. 2004. Biofilms and implant infections, p. 269293. In M. Ghannoum and, G. A. O’Toole (ed.), Microbial Biofilms. ASM Press, Washington, D.C.
82. Uhl, M. A., and, A. D. Johnson. 2001. Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology 147:11891195.
83. Vaughan, E. E.,, B. Mollet, and, W. M. deVos. 1999. Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel. Curr. Opin. Biotechnol. 10:505510.
84. Velraeds, M. M.,, B. van de Belt-Gritter,, H. C. van der Mei,, G. Reid, and, H. J. Busscher. 1998. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 47:10811085.
85. Wagner, R. D.,, C. Pierson,, T. Warner,, M. Dohnalek,, M. Hilty, and, E. Balish. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63:638644.
86. Zhou, X.,, S. J. Bent,, M. G. Schneider,, C. C. Davis,, M. R. Islam, and, L. J. Forney. 2004. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150:25652573.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error